混合性神经节细胞瘤-垂体腺瘤:诊断特征、临床管理与手术结局的系统综述
该系统综述遵循PRISMA指南检索多个数据库,纳入33项研究共78例经组织学确诊的混合性神经节细胞瘤-垂体腺瘤患者,分析其临床特征、管理策略与结局。中位诊断年龄47岁,女性占71%,常见表现为头痛(49%)、肢端肥大症(43%)和视力障碍(20%);经蝶手术为主要治疗策略,全切除率43%,术后92%患者垂体功能正常,末次随访总生存率97%。作者认为经蝶手术可实现较好的症状缓解和局部控制。
要点
- 混合性神经节细胞瘤-垂体腺瘤为罕见鞍区肿瘤,中位诊断年龄47岁,女性占71%。
- 常见表现包括头痛49%、肢端肥大症43%、视力障碍20%,生长激素和催乳素最常升高。
- 经蝶手术为主要策略,全切除率43%,术后92%垂体功能正常,总生存率97%。
核心结论
- 混合性神经节细胞瘤-垂体腺瘤是罕见的缓慢生长肿瘤,表现为内分泌和神经系统症状的组合。
- 作者认为经蝶手术是优化管理方式,尽管局部浸润发生率高且全切除率相对较低,仍似乎可实现较好的症状缓解和局部控制率。
研究设计与样本
- 遵循PRISMA指南检索PubMed、Embase、Web of Science和Cochrane数据库,纳入经组织学确诊的混合性神经节细胞瘤研究。
- 共纳入33项研究、78例患者,分析临床特征、管理策略和结局。
主要发现
- 中位诊断年龄47岁,女性占71%。
- 常见症状包括头痛49%、肢端肥大症43%、视力障碍20%;生长激素和催乳素为最常升高的激素。
- 磁共振成像显示86%患者存在局部浸润,最常累及海绵窦。
- 经蝶手术为主要治疗策略,全切除率43%;术后92%患者垂体功能正常。
- 中位随访21个月,14%患者因持续性激素高分泌需二次干预;二次干预后至末次随访,所有患者影像学和/或生化控制确认,总生存率97%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mixed gangliocytoma-pituitary adenomas (MGPAs) are very rare sellar neoplasms. Contemporary understanding of their natural history, clinical characteristics, optimal management strategies, and prototypical outcomes remains poorly understood. METHODS: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, PubMed, Embase, Web of Science, and Cochrane were searched to include studies of patients with histologically confirmed mixed gangliocytomas. Clinical features, management strategies, and outcomes were analyzed. RESULTS: Thirty three studies reporting 78 patients met study criteria and were included. Median age at diagnosis was 47 years, with a female predominance (71%). Common presenting symptoms included headache (49%), acromegaly (43%), and visual disturbance (20%). Growth hormone and prolactin were the most commonly elevated hormones. Magnetic resonance imaging identified local infiltration in 86% of patients, most frequently in the cavernous sinus. Transsphenoidal resection was the primary treatment strategy, which achieved a gross total resection in 43%. Postoperative pituitary function was normal in 92%. Median follow-up was 21 months, during which time 14% of patients required secondary intervention for persistent hormonal hypersecretion. Following these secondary interventions and as of last follow-up, radiographic and/or biochemical control was confirmed in all patients, with an overall survival rate of 97%. CONCLUSIONS: MGPAs are rare, slow-growing tumors that present with a combination of endocrinological and neurological symptoms. MGPAs are optimally managed with transsphenoidal resection, which appears to achieve favorable rates of symptomatic relief and local control despite the high incidence of local infiltration and relatively low attendant gross total resection rate.
引用
- Balasubramanian K, Andrade de Almeida RA, Kharbat AF, et al. Mixed Gangliocytoma-Pituitary Adenoma: A Systematic Review of Diagnostic Features, Clinical Management, and Surgical Outcomes. World Neurosurg. 2024. PMID: 39490575. doi:10.1016/j.wneu.2024.10.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。